Universities are encouraged to undertake research through grants from government agencies, foundations, and other organizations. The Bayh-Dole Act reinforces this incentive structure by allowing universities to take ownership of the resultant patents. Included in these rights is the ability to...

Patents have long been regarded as the 'gold standard' of intellectual property protection. In 'Little patents and big secrets: managing intellectual property', Anton and Yao (2004) call this traditional view into question by finding that firms keep their most important innovations secret. This...

Patents have long been regarded as the 'gold standard' of intellectual property protection. In "Little patents and big secrets: managing intellectual property", Anton and Yao (2004) call this traditional view into question by finding that firms keep their most important innovations secret. This...

We investigate whether patents that are jointly held by legally independent companies help sustain product-market collusion. We use a simple model of repeated interactions to show that joint patents can serve collusive purposes. Our model generates two testable predictions: when joint patents...

This paper utilizes a data set of over 208,000 U.S. patents applied for between 1975 and 2010 to study development of strategic patenting over time and across industries. With received citations as a measure of patent social value, we use data envelopment analysis to estimate firm-level relative...

This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of 74 countries. The identification strategy exploits the different timing across countries of two sets of IPR reforms. Domestic innovation is measured as citation-weighted...

Patents should no longer be granted for DNA, but only for new medicinal products, new vaccines and genetic tests which are developed on the basis of DNA. Only in this way, patent law can gain general acceptance in civil and academic society, without losing sight of the interests of the biotech...

This report provides the first edition of a European patent indicator for access to genetic resources and benefit-sharing developed for the European Environment Agency as part of the Streamlining European Biodiversity Indicators (SEBI 2010) process (Report EEA/BSS/08/012). The patent indicator...

The Italian and European regulatory framework for patents would benefit from further improvements in order to foster dynamic competition between Italian firms. At the national level the exclusive allocation of the right to patent inventions to universities, rather than to researchers, would...

De facto one of the indisputable shortage of patent laws proves the circumstance, that these have been made without beforehand defining there the legal term of real legal object/object of right – ‘patentable invention' and as a result of which there have been made centuries-old efforts to...